Report Detail

Other Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2022-2028

  • RnM4385575
  • |
  • 21 February, 2022
  • |
  • Global
  • |
  • 85 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.

Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other

Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Nucleic Acid Drugs Market Size 2022-2028
    • 2.1.2 Nucleic Acid Drugs Market Size CAGR by Region
  • 2.2 Nucleic Acid Drugs Segment by Type
    • 2.2.1 Antisense Nucleic Acid Drugs
    • 2.2.2 siRNA Drugs
    • 2.2.3 saRNA Drugs
    • 2.2.4 miRNA Drugs
    • 2.2.5 mRNA Drugs
    • 2.2.6 other
  • 2.3 Nucleic Acid Drugs Market Size by Type
    • 2.3.1 Global Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)
    • 2.3.2 Global Nucleic Acid Drugs Market Size Growth Rate by Type (2022-2028)
  • 2.4 Nucleic Acid Drugs Segment by Application
    • 2.4.1 Genetic Disease
    • 2.4.2 Cancer
    • 2.4.3 Cardiovascular Diseases
    • 2.4.4 Other
  • 2.5 Nucleic Acid Drugs Market Size by Application
    • 2.5.1 Global Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)
    • 2.5.2 Global Nucleic Acid Drugs Market Size Growth Rate by Application (2022-2028)

3 Nucleic Acid Drugs Key Players

  • 3.1 Date of Key Players Enter into Nucleic Acid Drugs
  • 3.2 Key Players Nucleic Acid Drugs Product Offered
  • 3.3 Key Players Nucleic Acid Drugs Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Nucleic Acid Drugs Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Nucleic Acid Drugs by Regions

  • 4.1 Nucleic Acid Drugs Market Size by Regions (2022-2028)
  • 4.2 United States Nucleic Acid Drugs Market Size Growth (2022-2028)
  • 4.3 China Nucleic Acid Drugs Market Size Growth (2022-2028)
  • 4.4 Europe Nucleic Acid Drugs Market Size Growth (2022-2028)
  • 4.5 Rest of World Nucleic Acid Drugs Market Size Growth (2022-2028)

5 United States

  • 5.1 United States Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 5.2 United States Nucleic Acid Drugs Market Size by Application (2022-2028)

6 China

  • 6.1 China Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 6.2 China Nucleic Acid Drugs Market Size by Application (2022-2028)

7 Europe

  • 7.1 Europe Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 7.2 Europe Nucleic Acid Drugs Market Size by Application (2022-2028)

8 Rest of World

  • 8.1 Rest of World Nucleic Acid Drugs Market Size by Type (2022-2028)
  • 8.2 Rest of World Nucleic Acid Drugs Market Size by Application (2022-2028)
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Key Investors in Nucleic Acid Drugs

  • 10.1 Company A
    • 10.1.1 Company A Company Details
    • 10.1.2 Company Description
    • 10.1.3 Companies Invested by Company A
    • 10.1.4 Company A Key Development and Market Layout
  • 10.2 Company B
    • 10.2.1 Company B Company Details
    • 10.2.2 Company Description
    • 10.2.3 Companies Invested by Company B
    • 10.2.4 Company B Key Development and Market Layout
  • 10.3 Company C
    • 10.3.1 Company C Company Details
    • 10.3.2 Company Description
    • 10.3.3 Companies Invested by Company C
    • 10.3.4 Company C Key Development and Market Layout
  • 10.4 Company D
  • 10.5 ……

11 Key Players Analysis

  • 11.1 Sarepta Therapeutics
    • 11.1.1 Sarepta Therapeutics Company Details
    • 11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
    • 11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.1.4 Sarepta Therapeutics Main Business Overview
    • 11.1.5 Sarepta Therapeutics News
  • 11.2 Ionis Pharmaceuticals
    • 11.2.1 Ionis Pharmaceuticals Company Details
    • 11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
    • 11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.2.4 Ionis Pharmaceuticals Main Business Overview
    • 11.2.5 Ionis Pharmaceuticals News
  • 11.3 Alnylam
    • 11.3.1 Alnylam Company Details
    • 11.3.2 Alnylam Nucleic Acid Drugs Product Offered
    • 11.3.3 Alnylam Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.3.4 Alnylam Main Business Overview
    • 11.3.5 Alnylam News
  • 11.4 Mina Therapeutics
    • 11.4.1 Mina Therapeutics Company Details
    • 11.4.2 Mina Therapeutics Nucleic Acid Drugs Product Offered
    • 11.4.3 Mina Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.4.4 Mina Therapeutics Main Business Overview
    • 11.4.5 Mina Therapeutics News
  • 11.5 BioNTech
    • 11.5.1 BioNTech Company Details
    • 11.5.2 BioNTech Nucleic Acid Drugs Product Offered
    • 11.5.3 BioNTech Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.5.4 BioNTech Main Business Overview
    • 11.5.5 BioNTech News
  • 11.6 NeXstar Pharmaceuticals
    • 11.6.1 NeXstar Pharmaceuticals Company Details
    • 11.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offered
    • 11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.6.4 NeXstar Pharmaceuticals Main Business Overview
    • 11.6.5 NeXstar Pharmaceuticals News
  • 11.7 Nippon Shinyaku
    • 11.7.1 Nippon Shinyaku Company Details
    • 11.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
    • 11.7.3 Nippon Shinyaku Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.7.4 Nippon Shinyaku Main Business Overview
    • 11.7.5 Nippon Shinyaku News
  • 11.8 Moderna Therapeutics
    • 11.8.1 Moderna Therapeutics Company Details
    • 11.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
    • 11.8.3 Moderna Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.8.4 Moderna Therapeutics Main Business Overview
    • 11.8.5 Moderna Therapeutics News
  • 11.9 CureVac
    • 11.9.1 CureVac Company Details
    • 11.9.2 CureVac Nucleic Acid Drugs Product Offered
    • 11.9.3 CureVac Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.9.4 CureVac Main Business Overview
    • 11.9.5 CureVac News
  • 11.10 Regulus Therapeutics
    • 11.10.1 Regulus Therapeutics Company Details
    • 11.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
    • 11.10.3 Regulus Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)
    • 11.10.4 Regulus Therapeutics Main Business Overview
    • 11.10.5 Regulus Therapeutics News
  • 11.11 Miragen Therapeutics

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Nucleic Acid Drugs. Industry analysis & Market Report on Nucleic Acid Drugs is a syndicated market report, published as Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nucleic Acid Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,938.98
5,877.96
3,422.10
6,844.20
567,775.80
1,135,551.60
305,061.00
610,122.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report